Goldman Sachs
GS
$931.30
-0.38%
The Goldman Sachs Group Inc. is a leading global investment bank and financial services firm, operating primarily in capital markets through investment banking, global market making and trading, asset and wealth management, and lending. It is a dominant market leader, particularly in merger and acquisition advisory where it has been the top global provider by revenue for two decades, and has strategically expanded into more stable, fee-based businesses like asset and wealth management. The current investor narrative centers on the firm's strategic pivot towards these recurring revenue streams to reduce earnings volatility, while navigating a complex macroeconomic environment marked by geopolitical tensions impacting markets, as evidenced by recent news on peace-talk collapses roiling markets and the transformative acquisition of Innovator ETFs to scale its asset management footprint.…
GS
Goldman Sachs
$931.30
Related headlines
Investment Opinion: Should I buy GS Today?
Rating: Hold. The core thesis is that Goldman Sachs' strategic merits are currently offset by significant cash flow concerns and a premium valuation, warranting a wait-and-see approach despite a favorable long-term narrative.
Supporting evidence for this Hold rating includes a forward P/E of 14.17x, which is reasonable but not compelling given the risks. Profitability is strong with a 13.74% ROE, and the strategic acquisition of Innovator ETFs provides a tangible catalyst for growth in stable fees. However, these positives are counterbalanced by the severe -$47.22B TTM free cash flow and the 6.56% YoY revenue decline in Q4, indicating near-term operational headwinds. Analyst sentiment is neutral-to-slightly-bullish (e.g., 'Overweight', 'Market Perform'), reflecting this balanced but cautious outlook.
The thesis would upgrade to a Buy if the firm demonstrates a clear path to positive free cash flow generation or if revenue re-accelerates above 5% YoY, validating the growth priced into the forward multiple. It would downgrade to a Sell if quarterly cash flow remains deeply negative for another two quarters or if the debt-to-equity ratio climbs above 5.5. Relative to its own historical P/E range (8x-23x) and peers, the stock is fairly valued to slightly overvalued, pricing in a successful execution of its strategic pivot that is not yet fully evident in the financials.
Sign up to view all
GS 12-Month Price Forecast
Goldman Sachs presents a classic 'show me' story. The long-term strategic rationale for pivoting to asset management is sound and supported by the transformative Innovator ETF deal. However, the near-term financials reveal significant strain, with declining revenue and deeply negative cash flows that cannot be ignored. The stock's premium valuation (16x trailing P/E) already prices in a successful transition, leaving limited margin for error. The stance is neutral due to this high degree of execution risk offset by the firm's undeniable franchise strength. Confidence is medium because the cash flow issue is a significant unknown. The stance would upgrade to bullish on evidence of sustained revenue growth and cash flow turning positive. It would turn bearish if the next two quarters show further revenue deceleration and no improvement in cash generation.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Goldman Sachs's 12-month outlook, with a consensus price target around $1210.69 and implied upside of +30.0% versus the current price.
Average Target
$1210.69
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$745 - $1211
Analyst target range
Analyst coverage for Goldman Sachs appears limited in the provided dataset, with only 5 analysts cited, which is unusually low for a mega-cap financial institution; this likely indicates the data is incomplete. For the analysts tracked, the consensus recommendation leans neutral to slightly bullish, with recent institutional ratings including 'Overweight' from Barclays and Wells Fargo, 'Market Perform' from KBW, and 'Neutral' from JP Morgan. The average target price is not explicitly provided in the data, so implied upside cannot be calculated from the given inputs. The target range for estimated EPS is from $70.91 to $80.38, and for revenue, it is $65.60 billion to $72.24 billion, indicating a moderate spread in expectations. The high-end targets likely assume a robust recovery in capital markets activity, successful integration of strategic acquisitions like Innovator ETFs, and expanding margins in the asset management division. The low-end targets likely factor in persistent macroeconomic headwinds, volatile trading revenues, and potential compression in investment banking fees. The recent pattern of analyst actions shows stability, with most firms maintaining their ratings over the past few months, suggesting a wait-and-see approach pending clearer evidence of the strategic pivot's success.
Bulls vs Bears: GS Investment Factors
The investment thesis for Goldman Sachs is defined by a tension between its elite, high-margin franchise and strategic pivot towards stability versus its cyclical revenue base and alarming cash flow profile. The bull case is supported by strong profitability, a dominant market position, and a credible shift to asset management. The bear case is grounded in deteriorating revenue momentum, severe negative cash generation, and a premium valuation that discounts significant future success. Currently, the bearish evidence carries more immediate weight due to the concrete, negative cash flow data and revenue deceleration, which pose tangible near-term risks. The single most important tension is whether the firm's strategic investments in fee-based businesses can successfully offset the volatility and cash intensity of its legacy trading operations before a macroeconomic slowdown tests its leveraged balance sheet.
Bullish
- Dominant M&A Franchise: Goldman Sachs has been the top global M&A advisor by revenue for two decades, providing a durable competitive moat. This leadership in high-margin advisory work underpins the firm's premium valuation and provides a stable foundation for earnings.
- Strong Profitability & ROE: The firm maintains robust profitability with a Q4 2025 net margin of 15.33% and a trailing Return on Equity of 13.74%. These metrics exceed many banking peers and justify a valuation premium, demonstrating efficient capital allocation.
- Strategic Pivot to Recurring Fees: The acquisition of Innovator ETFs ($31B AUM) and the growth of Asset & Wealth Management to ~30% of revenue represent a strategic shift towards more stable, fee-based income. This reduces reliance on volatile trading revenues and supports a higher earnings multiple.
- Attractive Forward Valuation: With a forward P/E of 14.17x, the stock trades at an 11% discount to its trailing P/E of 16.00x, implying the market expects earnings growth. This forward multiple is reasonable given analyst EPS estimates averaging $75.79, a significant jump from recent quarterly EPS of $14.21.
Bearish
- Severe Negative Cash Flow: Trailing twelve-month free cash flow is deeply negative at -$47.22 billion, and Q4 operating cash flow was -$16.28 billion. This alarming cash burn, despite positive net income, raises questions about the sustainability of capital returns and indicates heavy working capital needs in its trading books.
- Revenue Deceleration & Cyclicality: Q4 2025 revenue of $30.13B declined 6.56% YoY, and the quarterly sequence from Q1 to Q4 2025 shows a clear downtrend. This highlights the inherent cyclicality of its core Global Markets business, which generated $20.63B of the quarter's revenue, making earnings vulnerable to a market downturn.
- High Financial Leverage: A debt-to-equity ratio of 4.88, while typical for a large bank, indicates substantial financial risk. This elevated leverage amplifies downside risks in a rising interest rate environment or during a credit cycle downturn.
- Premium Valuation vs. Peers: A trailing P/E of 16.00x and P/B of 2.20x sit above the typical range for large-cap financials. This premium leaves the stock vulnerable to multiple compression if earnings growth falters or if investor sentiment shifts away from premium-priced financials.
GS Technical Analysis
The stock is in a sustained long-term uptrend but has recently experienced significant volatility and a pullback from its highs. Over the past year, the price has surged 81.74%, indicating powerful bullish momentum, and the current price of $925.95 sits at approximately 94% of its 52-week high of $984.70, suggesting the stock is trading near the top of its range but has retreated from the absolute peak. This positioning near highs reflects strong investor confidence but also raises concerns about potential overextension and vulnerability to profit-taking, as seen in the recent pullback from the January peak. Recent momentum shows a stark divergence from the long-term trend, with the stock down 3.75% over the past three months but up 14.96% over the past month. This 1-month surge, which significantly outperformed the SPY's 7.36% gain, suggests a strong recovery attempt from the March lows around $782, indicating the longer-term uptrend may be reasserting itself after a corrective phase. The stock's beta of 1.311 confirms it is approximately 31% more volatile than the broader market, which amplifies both gains and losses and is a critical factor for risk-aware investors. Key technical levels are clearly defined by the 52-week high of $984.70 as major resistance and the 52-week low of $494.68 as distant support. A decisive breakout above the $985 resistance would signal a resumption of the primary bull trend and target new highs, while a failure here could lead to further consolidation. The stock has already experienced a significant drawdown of -21.11% from its peak, testing intermediate support, and its high beta implies investors should expect continued elevated volatility relative to the market, necessitating careful position sizing.
Beta
1.31
1.31x market volatility
Max Drawdown
-21.1%
Largest decline past year
52-Week Range
$523-$985
Price range past year
Annual Return
+75.9%
Cumulative gain past year
| Period | GS Return | S&P 500 |
|---|---|---|
| 1m | +11.4% | +8.5% |
| 3m | +1.4% | +2.8% |
| 6m | +18.8% | +4.6% |
| 1y | +75.9% | +32.3% |
| ytd | +1.9% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GS Fundamental Analysis
Revenue growth has been inconsistent, with the most recent quarterly revenue of $30.13 billion representing a year-over-year decline of 6.56%. Analyzing the quarterly sequence for fiscal 2025 shows revenue peaked in Q1 at $31.55 billion and has trended downward through Q4, indicating a deceleration in top-line momentum. Segment data, though limited, shows Global Markets generated $20.63 billion and Investment Management $9.22 billion, suggesting trading and market-making activities remain the primary revenue driver, which are inherently more cyclical than the firm's strategic focus on asset management. Profitability remains robust with a net income of $4.62 billion in Q4 2025, translating to a net margin of 15.33%. Gross margin for the quarter was a healthy 51.71%, and the operating margin was 19.44%. However, examining the trend from Q1 to Q4 2025 shows net income has fluctuated ($4.74B, $3.72B, $4.10B, $4.62B) while gross margins have generally improved sequentially (46.83%, 45.41%, 46.17%, 51.71%), indicating some success in managing the cost of revenue despite the top-line pressure. The balance sheet shows significant leverage with a debt-to-equity ratio of 4.88, which is typical for a large bank but indicates substantial financial risk. More concerning is the cash flow picture: trailing twelve-month free cash flow is deeply negative at -$47.22 billion, and the latest quarterly operating cash flow was -$16.28 billion. This severe negative cash generation, against a Return on Equity of 13.74%, suggests profits are not currently converting to cash, likely due to significant investments and changes in working capital within its trading and lending books, raising questions about the sustainability of capital returns like share buybacks.
Quarterly Revenue
$30.1B
2025-12
Revenue YoY Growth
-0.06%
YoY Comparison
Gross Margin
+0.51%
Latest Quarter
Free Cash Flow
$-47.2B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GS Overvalued?
Given the company's substantial positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 16.00x, while the forward PE is lower at 14.17x. This discount of approximately 11% for the forward multiple implies the market anticipates earnings growth, aligning with analyst EPS estimates that average $75.79 for the coming period, a significant increase from the recent quarterly EPS of $14.21. Compared to industry averages, Goldman Sachs trades at a premium on several metrics. Its trailing PE of 16.00x is above the typical range for large-cap financials, which often trade between 10x-14x. The Price-to-Sales ratio of 2.20x and Price-to-Book ratio of 2.20x also suggest a valuation premium relative to many traditional banking peers. This premium is likely justified by the firm's elite investment banking franchise, higher-margin asset management business, and superior return on equity of 13.74%, which exceeds many commercial bank peers. Historically, the stock's current trailing PE of 16.00x sits above its own multi-year range observed in the historical data, which has fluctuated between approximately 8x and 23x over recent years. Being in the upper half of its historical band suggests the market is pricing in a relatively optimistic outlook for earnings recovery and strategic execution. However, it is not at the extreme highs seen during peak profit cycles, leaving some room for multiple expansion if the firm successfully delivers on its growth and margin targets.
PE
16.0x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 4x~23x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
30.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced, centered on cash flow and revenue concentration. The staggering -$47.22 billion TTM free cash flow indicates profits are not converting to usable cash, likely tied to inventory and receivable movements in its trading book, which could constrain shareholder returns. Revenue remains heavily dependent on the cyclical Global Markets segment, which contributed over 68% of Q4 revenue, exposing the firm to downturns in trading activity and investment banking fees, as seen in the 6.56% YoY revenue decline. Furthermore, the high debt-to-equity ratio of 4.88 increases refinancing risk and interest expense sensitivity.
Market & Competitive Risks include valuation compression and competitive disruption. Trading at a trailing P/E of 16.00x—a premium to many financial peers—the stock is vulnerable to derating if earnings growth, implied by the forward P/E of 14.17x, fails to materialize. Competitors like JPMorgan are demonstrating tangible cost savings from AI investments, potentially gaining an efficiency edge. Macro risks are heightened by the stock's beta of 1.31, making it sensitive to market swings driven by geopolitical events (e.g., collapsed peace talks roiling markets) and oil price shocks that could dampen capital markets activity.
The Worst-Case Scenario involves a perfect storm of a sustained capital markets downturn and a liquidity crunch. A severe recession collapses M&A and trading volumes, causing revenue to fall towards the analyst low estimate of $65.6B while margins compress. The negative cash flow prevents the firm from easily weathering the storm, potentially forcing asset sales or a cut to capital returns. In this scenario, the stock could realistically re-test its 52-week low of $494.68, representing a potential loss of approximately -47% from the current price of $925.95, mirroring the -21.11% drawdown already experienced but extending it significantly.
FAQ
The key risks, in order of severity, are: 1) Financial Risk: The alarming -$47.22 billion TTM free cash flow raises liquidity and capital return sustainability concerns. 2) Cyclical Revenue Risk: Heavy dependence on volatile Global Markets revenue (over 68% of Q4), which is already showing a 6.56% YoY decline. 3) Leverage Risk: A high debt-to-equity ratio of 4.88 increases vulnerability to rising rates and economic stress. 4) Valuation Risk: Trading at a premium P/E (16x) leaves the stock exposed to multiple compression if growth stalls.
The 12-month forecast presents three scenarios. The Base Case (50% probability) targets $850-$984, assuming the firm meets analyst EPS estimates near $75.79 amid a mixed macro environment. The Bull Case (30% probability) targets $984-$1100, driven by a capital markets boom and successful strategic execution. The Bear Case (20% probability) targets $495-$750, triggered by a deep recession and worsening cash flows. The Base Case is most likely, hinging on the critical assumption that revenue stabilizes and begins to grow towards analyst estimates without a further deterioration in cash generation.
GS appears fairly valued to slightly overvalued relative to its current fundamentals but undervalued if its strategic plans succeed. Its trailing P/E of 16.00x and P/B of 2.20x command a premium over many banking peers, justified by its higher ROE (13.74%) and elite franchise. However, this premium valuation implies the market expects significant earnings growth, as seen in the forward P/E discount to 14.17x. Compared to its own historical P/E range (approx. 8x-23x), it sits in the upper half, suggesting the market is pricing in optimism but not irrational exuberance.
GS is a conditional buy, suitable only for investors comfortable with significant volatility and execution risk. The potential upside is tied to a successful strategic pivot and earnings recovery, with a forward P/E of 14.17x offering a reasonable entry if growth materializes. However, the severe negative cash flow (-$47.22B TTM) and recent revenue decline present substantial near-term risks. It is a good buy for long-term, risk-tolerant investors who believe management can navigate these challenges, but not for those seeking stability or income.
GS is primarily suitable for a long-term investment horizon of 3-5 years. Its high beta of 1.311 makes it too volatile for most short-term traders, and its investment thesis is predicated on a multi-year strategic transformation into a more stable, fee-based business. The low dividend yield (1.9%) does not support an income strategy. Long-term investors can better weather the cyclical earnings volatility and await the potential payoff from the asset management pivot. A minimum holding period of 18-24 months is suggested to assess the success of key initiatives like the Innovator ETF integration.